Molecular responses to xenoestrogens: mechanistic insights from toxicogenomics

Jonathan G Moggs1

  • 1Syngenta Central Toxicology Laboratory, Alderley Park, Cheshire SK10 4TJ, UK. jonathan.moggs@syngenta.com

Toxicology
|July 6, 2005
PubMed

Insights

Xenoestrogens disrupt reproductive health by interfering with sex steroid pathways. Toxicogenomics, using gene expression profiling, offers new mechanistic insights into xenoestrogen action and safety assessment.

Area of Science:

  • Endocrinology and Toxicology
  • Molecular Biology and Genomics

Background:

  • Xenoestrogens, environmental chemicals, can disrupt endocrine systems, particularly reproductive and developmental processes, by interacting with sex steroid nuclear receptors.
  • Understanding xenoestrogen molecular interactions is crucial for accurate safety assessments and risk evaluation.

Discussion:

  • Toxicogenomics, especially microarray-based gene expression profiling, enables simultaneous measurement of thousands of genes, providing insights into cellular responses.
  • Estrogen receptors, as ligand-activated transcription factors, mediate cellular responses to xenoestrogens, making toxicogenomics a powerful tool for studying their mechanisms.
  • Linking gene expression changes to physiological and toxicological outcomes is a key challenge in endocrine disruptor research.

Key Insights:

  • Gene Ontology and Pathway Mapping, along with Phenotypic Anchoring, connect xenoestrogen-induced gene expression changes to biological pathways.
  • Combining transcript profiling with transgenic models or modified cell systems enhances mechanistic understanding of xenoestrogen-target gene interactions.
  • Toxicogenomic approaches provide extensive mechanistic data on molecular responses to xenoestrogens.

Outlook:

  • These toxicogenomic methods are revolutionizing the study of xenoestrogen molecular responses.
  • The insights gained will significantly impact the hazard and risk assessment of endocrine-disrupting chemicals.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Toxicokinetics: Overview01:21

Toxicokinetics: Overview

Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...